Atlantic International Corp. (ATLN)
USD 3.95
(1.8%)
USD 3.95
(1.8%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -5.62 Million USD | -37.43% |
| 2022 | -4.09 Million USD | -10.56% |
| 2021 | -3.7 Million USD | -254.29% |
| 2020 | -1.04 Million USD | 57.74% |
| 2019 | -2.47 Million USD | 14.35% |
| 2018 | -2.88 Million USD | -69.19% |
| 2017 | -1.7 Million USD | -19.0% |
| 2016 | -1.43 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -1.09 Million USD | 11.75% |
| 2024 Q2 | -54.91 Million USD | -4912.11% |
| 2023 Q1 | -1.71 Million USD | -39.02% |
| 2023 Q2 | -1.4 Million USD | 18.52% |
| 2023 Q4 | -1.24 Million USD | 2.07% |
| 2023 FY | -5.62 Million USD | -37.43% |
| 2023 Q3 | -1.26 Million USD | 9.46% |
| 2022 Q1 | -937.95 Thousand USD | 32.87% |
| 2022 Q3 | -925.94 Thousand USD | 6.93% |
| 2022 Q2 | -994.91 Thousand USD | -6.07% |
| 2022 FY | -4.09 Million USD | -10.56% |
| 2022 Q4 | -1.23 Million USD | -33.49% |
| 2021 Q4 | -1.39 Million USD | -118.47% |
| 2021 FY | -3.7 Million USD | -254.29% |
| 2021 Q3 | -639.49 Thousand USD | 0.0% |
| 2020 FY | -1.04 Million USD | 57.74% |
| 2019 FY | -2.47 Million USD | 14.35% |
| 2018 FY | -2.88 Million USD | -69.19% |
| 2017 FY | -1.7 Million USD | -19.0% |
| 2016 FY | -1.43 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -299.12% |
| Arrayit Corporation | -3.31 Million USD | -69.731% |
| Biocept, Inc. | -32.08 Million USD | 82.461% |
| Bioqual, Inc. | 483.48 Thousand USD | 1263.974% |
| CardioGenics Holdings Inc | -1.91 Million USD | -193.666% |
| DermTech, Inc. | -100.88 Million USD | 94.422% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.278% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 73.94% |
| iMD Companies, Inc. | -200.63 Thousand USD | -2704.876% |
| IDenta Corp. | 14.64 Thousand USD | 38529.329% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 801.695% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 14645.713% |
| InVitro International | 1553.00 USD | 362469.028% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 34.502% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -9584.043% |
| Medical Imaging Corp. | -3.02 Million USD | -86.158% |
| NovelStem International Corp. | -4.18 Million USD | -34.397% |
| Optigenex Inc. | -2.89 Million USD | -94.205% |
| PharmChem, Inc. | 845.1 Thousand USD | 765.907% |
| Proteome Sciences plc | -2.44 Million USD | -130.356% |
| Response Genetics, Inc | -20.18 Million USD | 72.119% |
| Rennova Health, Inc. | -3.29 Million USD | -70.893% |
| RushNet, Inc. | -607.02 Thousand USD | -827.073% |
| ScreenPro Security Inc. | -2.24 Million USD | -150.252% |
| Stella Diagnostics Inc. | -5.7 Million USD | 1.399% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 50.702% |
| Todos Medical Ltd. | -24.99 Million USD | 77.484% |